Genzyme Shareholder Sues Over Sanofi Bid Rejection
By Allison Grande ( September 9, 2010, 4:13 PM EDT) -- A Genzyme Corp. investor has launched a putative class action alleging the company's rejection of Sanofi-Aventis SA's $18.5 billion offer to buy it has deprived Genzyme stockholders of the right to receive the maximum value for their shares....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.